JONATHAN KISER: Open Payments
NPI 1235866484 · SALEM, OR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,385 in 71 payments from 13 companies in 2025. Trend: 2023 $567 · 2024 $1,729 · 2025 $1,385
Food & beverage: $1,303Education: $82
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 15 | $322 |
| ABBVIE INC. | 20 | $273 |
| Amgen Inc. | 5 | $144 |
| GENZYME CORPORATION | 8 | $143 |
| Novartis Pharmaceuticals Corporation | 6 | $116 |
| Lilly USA, LLC | 3 | $79 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 2 | $66 |
| Organon LLC | 2 | $45 |
| LEO Pharma Inc. | 2 | $44 |
| Regeneron Healthcare Solutions, Inc. | 2 | $42 |
Products named: TREMFYA, SKYRIZI, DUPIXENT, Otezla, COSENTYX, RINVOQ, ILUMYA, TALTZ.
Industry payments across OR — which companies pay providers there.
